Metabolic and Endocrine Consequences of Bariatric/metabolic Surgery

Bariatric surgery evolved from interventions directed primarily to treating obesity and metabolic surgery to treat metabolic disorders, especially type 2 diabetes, in last decades. Long-term follow-up of operated patients provided evidences of nutritional, metabolic, pharmacological and endocrine consequences of bariatric and metabolic interventions. Some of them are beneficial for patients, such as reduction of body weight, improvement of obesity associated metabolic diseases (diabetes and dyslipidaemia), reduction of blood pressure, improvement in individual’s functional status and improvement in psychological health. On the other side, there are deleterious consequences that result into potential complications of bariatric and metabolic surgery. Complications after bariatric surgery are usually divided into the immediate intraoperative, late and metabolic complications. Sometimes additional therapy is necessary to treat induced endocrine alterations. Further research is needed to explore expected benefits of metabolic surgery as well as its disadvantages concerning potential complications.

We encourage contributions to this topic exploring the relationship between metabolic surgery and:
- Mechanism of Type 2 diabetes remission after bariatric surgery;
- Functioning of GH/IGF-1 axis after bariatric surgery:
- Functioning of HPA axis ;
- Functioning of female gonadal function;
-Functioning of male reproductive function
-Bone metabolism

This Research Topic aims to collect evidences about consequences of bariatric surgery in metabolic and endocrine field, in order to develop and upgrade our current recommendations for the post-operative follow-up with patients.